Literature DB >> 26585627

Trends in the Use of Mechanical Circulatory Support Devices in Patients Presenting With ST-Segment Elevation Myocardial Infarction.

Shikhar Agarwal, Karan Sud, Joseph M Martin, Venu Menon.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26585627     DOI: 10.1016/j.jcin.2015.07.015

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


× No keyword cloud information.
  10 in total

Review 1.  Management of refractory cardiogenic shock.

Authors:  Alex Reyentovich; Maya H Barghash; Judith S Hochman
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 2.  Nephrology Considerations in the Management of Durable and Temporary Mechanical Circulatory Support.

Authors:  Carl P Walther; Andrew B Civitello; Kenneth K Liao; Sankar D Navaneethan
Journal:  Kidney360       Date:  2022-01-14

3.  Myocardial Injury Promotes Matrix Metalloproteinase-9 Activity in the Renal Cortex in Preclinical Models of Acute Myocardial Infarction.

Authors:  Xiaoying Qiao; Shreyas Bhave; Lija Swain; Elric Zweck; Lara Reyelt; Paige Crowley; Shiva K Annamalai; Aditya Chennjorwala; Michele Esposito; Allen Razavi; Sina Foroutanjazi; Cody Machen; Katherine Thayer; Lena Jorde; Richard H Karas; Navin K Kapur
Journal:  J Cardiovasc Transl Res       Date:  2021-03-29       Impact factor: 3.216

4.  Mechanical assist devices for acute cardiogenic shock.

Authors:  Tamara Ni hIci; Henry Mp Boardman; Kamran Baig; Jody L Stafford; Cristina Cernei; Owen Bodger; Stephen Westaby
Journal:  Cochrane Database Syst Rev       Date:  2020-06-04

5.  Veno-arterial extracorporeal membrane oxygenation in addition to primary PCI in patients presenting with ST-elevation myocardial infarction.

Authors:  F S van den Brink; A D Magan; P G Noordzij; C Zivelonghi; P Agostoni; F D Eefting; J M Ten Berg; M J Suttorp; B R Rensing; J P van Kuijk; P Klein; E Scholten; J A S van der Heyden
Journal:  Neth Heart J       Date:  2018-02       Impact factor: 2.380

6.  Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery.

Authors:  Saraschandra Vallabhajosyula; Shilpkumar Arora; Sopan Lahewala; Varun Kumar; Ghanshyam P S Shantha; Jacob C Jentzer; John M Stulak; Bernard J Gersh; Rajiv Gulati; Charanjit S Rihal; Abhiram Prasad; Abhishek J Deshmukh
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

7.  Utilization of Palliative Care for Cardiogenic Shock Complicating Acute Myocardial Infarction: A 15-Year National Perspective on Trends, Disparities, Predictors, and Outcomes.

Authors:  Saraschandra Vallabhajosyula; Abhiram Prasad; Shannon M Dunlay; Dennis H Murphree; Cory Ingram; Paul S Mueller; Bernard J Gersh; David R Holmes; Gregory W Barsness
Journal:  J Am Heart Assoc       Date:  2019-07-18       Impact factor: 5.501

8.  Use of Vasoactive Medications after Cardiac Surgery in the United States.

Authors:  Emily A Vail; Meng-Shiou Shieh; Penelope S Pekow; Hayley B Gershengorn; Allan J Walkey; Peter K Lindenauer; Hannah Wunsch
Journal:  Ann Am Thorac Soc       Date:  2021-01

9.  Predicting mortality in cardiogenic shock secondary to ACS requiring short-term mechanical circulatory support: The ACS-MCS score.

Authors:  Qussay Marashly; Iosif Taleb; Christos P Kyriakopoulos; Elizabeth Dranow; Tara L Jones; Anwar Tandar; Sean D Overton; Joseph E Tonna; Kathleen Stoddard; Omar Wever-Pinzon; Line Kemeyou; Antigone G Koliopoulou; Kevin S Shah; Kimiya Nourian; Tyler J Richins; Tyson S Burnham; Frederick G Welt; Stephen H McKellar; Jose Nativi-Nicolau; Stavros G Drakos
Journal:  Catheter Cardiovasc Interv       Date:  2021-03-07       Impact factor: 2.692

10.  Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention.

Authors:  F S van den Brink; T A Meijers; S H Hofma; A J van Boven; A Nap; A Vonk; P Symersky; K D Sjauw; P Knaapen
Journal:  Neth Heart J       Date:  2020-03       Impact factor: 2.380

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.